Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease. [electronic resource]
Producer: 20131204Description: 892-9 p. digitalISSN:- 1556-679X
- Animals
- Antibodies, Bacterial -- therapeutic use
- Bacterial Load
- Bacterial Outer Membrane Proteins -- immunology
- Bacterial Vaccines -- administration & dosage
- Disease Models, Animal
- Female
- Immunization, Passive
- Lyme Disease -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C3H
- Treatment Outcome
- Vaccines, Synthetic -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.